Document Detail


Long-term survival in acute leukemia. Twenty-two adult patients surviving for over five years.
MedLine Citation:
PMID:  3456695     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
An intermittent combination chemotherapy program was initiated in 1971-79 in 172 patients, aged 15-59 years, with acute leukemia (131 myelogenous (AML) and 41 lymphoblastic (ALL]. Sixteen patients with AML and 6 with ALL have survived for more than 5 years. These long-term survivors represent 24% of AML and 18% of ALL patients who obtained complete remission. Twelve patients (10 AML and 2 ALL) are in continuous first remission 5.5-13.5 years after diagnosis. Occasional late relapses up to 9 years after diagnosis make it impossible to declare any individual patient cured.
Authors:
S A Evensen; P Stavem
Related Documents :
17008705 - Prospective evaluation of clonal evolution during long-term follow-up of patients with ...
6452195 - Hypercalcemia in the accelerated phase of chronic myelogenous leukemia.
18055345 - Acute myeloid leukemia with multilineage dysplasia in children.
12550755 - Interphase fluorescence in situ hybridization analysis of del(11)(q23) and del(17)(p13)...
10896355 - The role of carbonic anhydrase inhibitors in the management of macular edema.
1829145 - Bezoars: a special cause of ileal obstruction in mentally retarded patients.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Acta medica Scandinavica     Volume:  219     ISSN:  0001-6101     ISO Abbreviation:  Acta Med Scand     Publication Date:  1986  
Date Detail:
Created Date:  1986-04-09     Completed Date:  1986-04-09     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0370330     Medline TA:  Acta Med Scand     Country:  SWEDEN    
Other Details:
Languages:  eng     Pagination:  79-83     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Female
Follow-Up Studies
Humans
Leukemia, Lymphoid / drug therapy,  mortality*
Leukemia, Myeloid, Acute / drug therapy,  mortality*
Male
Middle Aged
Prognosis

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Mandibular dysfunction in adolescents. II. Prevalence of signs.
Next Document:  Parameters that bias the measurement of airborne concentration within a respirator.